Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Windlas Biotech Ltd. ( (IN:WINDLAS) ) has issued an update.
Windlas Biotech Ltd. has announced a scheduled meeting with investors and analysts on March 17, 2025, which will be conducted virtually. This meeting is part of the company’s ongoing efforts to maintain transparency and engage with stakeholders, potentially impacting its market perception and investor relations.
More about Windlas Biotech Ltd.
Windlas Biotech Ltd. operates in the pharmaceutical industry, focusing on the manufacturing and development of pharmaceutical formulations. The company is involved in the production of a wide range of products, catering to various therapeutic segments, and aims to serve both domestic and international markets.
YTD Price Performance: -10.38%
Average Trading Volume: 6,567
Current Market Cap: 19.68B INR
For an in-depth examination of WINDLAS stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue